FindTrial
Sign In

A study to compare efficacy of 0.2 % Ropivacaine and morphine in Intrathecal versus Epidural in patients undergoing laparotomy.

Efficacy of single bolus epidural injection of 0.2% ropivacaine and morphine versus intrathecal 0.2% ropivacaine and morphine in patients undergoing laparotomy- a comparative study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036548
Enrollment
60
Registered
2021-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C171- Malignant neoplasm of jejunum

Interventions

Intervention1: Ropivacaine, Morphine: 0.2 % Ropivacaine and 2 mg morphine epidural bolus will be given once before inducing General Anaesthesia Frequency- Only once Route of administration - Epidural

Sponsors

NORI HARI CHANDAN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA GRADE 1 AND 2. PATIENTS UNDERGOING LAPAROTOMY UNDER GENERAL ANESTHESIA.

Exclusion criteria

Exclusion criteria: REFUSAL BY PATIENT TO PARTICIPATE IN STUDY. ALLERGIES TO LOCAL ANAESTHETICS OR STUDY DRUG. ANY CONTRAINDICATION TO REGIONAL ANAESTHESIA. ASA 3 AND 4. NEUROLOGICAL DISEASES. PATIENTS PHYSICALLY DEPENDENT ON OPIOIDS.

Design outcomes

Primary

MeasureTime frame
Patients receiving epidural bolus of 0.2% ropivacaine and morphine will need less intraoperative analgesia and longer postoperative pain free period.Timepoint: 10 months—

Secondary

MeasureTime frame
To study the adverse effects of drugs used in the study.Timepoint: 10 months—

Countries

India

Contacts

Public ContactDr Soumya samal

SOA UNIVERSITY

samalsoumya11@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026